pediatric patient of both gender between 1 and 16 year of age receive cbz or vpa mono-therapy will be recruit for this study additionally for those patient who be receive drug other than cbz or vpa to control their seizure if cbz or vpa be subsequently add to their treatment regimen then these patient will also be recruit for this study 